A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas.
about
Salvage Therapy in Advanced Adult Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis of Randomized Trials.Selumetinib in the treatment of non-small-cell lung cancer.Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma.Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials.Emerging targets in sarcoma: Rising to the challenge of RAS signaling in undifferentiated pleomorphic sarcoma.Deconstructing Signaling Pathways in Cancer for Optimizing Cancer Combination Therapies.Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma.
P2860
Q38611179-817538E4-9775-4140-A133-803FFA62CF36Q38836927-E7D9E23D-6AC5-4406-8EA0-6AB3613FB982Q42705608-9BE04DA0-8738-4351-B074-602937343E20Q46451484-D35F480A-49C0-40C4-B855-124D249ABA01Q48005435-D3E185AE-A279-4FE0-AF5F-18303823D805Q48097821-72DE0122-2943-4705-A866-D90531A328D9Q54239575-22192ED3-6963-42BA-BF18-3D887AF70106Q54969934-3C594680-2C5B-49DC-AB40-E031F024C5E3Q55262749-D56AF51B-4F9B-491D-91CE-0DE2DD9E4016
P2860
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A randomised phase II trial of ...... imus for soft-tissue sarcomas.
@ast
A randomised phase II trial of ...... imus for soft-tissue sarcomas.
@en
type
label
A randomised phase II trial of ...... imus for soft-tissue sarcomas.
@ast
A randomised phase II trial of ...... imus for soft-tissue sarcomas.
@en
prefLabel
A randomised phase II trial of ...... imus for soft-tissue sarcomas.
@ast
A randomised phase II trial of ...... imus for soft-tissue sarcomas.
@en
P2093
P2860
P356
P1476
A randomised phase II trial of ...... imus for soft-tissue sarcomas.
@en
P2093
D R Gandara
P H Frankel
S Christensen
S Wilczynski
P2860
P2888
P304
P356
10.1038/BJC.2015.126
P407
P577
2015-04-21T00:00:00Z